CONMED Corporation
CONMED Corporation, a leading player in the medical technology industry, is headquartered in the United States. Founded in 1970, the company has established a strong presence in various operational regions, including North America, Europe, and Asia. Specialising in surgical and patient monitoring products, CONMED is renowned for its innovative solutions in areas such as orthopaedics, general surgery, and endoscopy. The company’s core offerings include advanced surgical instruments, electrosurgical devices, and video imaging systems, all designed to enhance surgical precision and patient outcomes. Notably, CONMED has achieved significant milestones, including the development of cutting-edge technologies that set industry standards. With a commitment to quality and innovation, CONMED Corporation continues to solidify its market position as a trusted provider of medical devices, making a meaningful impact in healthcare worldwide.
DitchCarbon Score
How does CONMED Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CONMED Corporation's score of 19 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CONMED Corporation's reported carbon emissions
In 2024, CONMED Corporation reported total carbon emissions of approximately 1,103,900 kg CO2e. This figure includes 142,140 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 9,270 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity. The majority of their emissions, about 952,490 kg CO2e, fall under Scope 3, which encompasses all other indirect emissions that occur in the value chain. Comparatively, in 2023, CONMED's Scope 3 emissions were reported at approximately 912,400 kg CO2e, indicating a slight increase in emissions year-on-year. Currently, CONMED Corporation has not established specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to the Science Based Targets initiative (SBTi). The company is not reported to inherit emissions data from any parent organisation, maintaining its own emissions reporting and climate commitments independently. As a medical technology company headquartered in the US, CONMED is positioned within an industry that increasingly prioritises sustainability and carbon footprint reduction, yet it has yet to publicly commit to specific climate pledges or reduction strategies.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CONMED Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
